Literature DB >> 17105409

Transgenic human fetal fibroblasts as feeder layer for human embryonic stem cell lineage selection.

Kuldip S Sidhu1, Khun Hong D Lie, Bernard E Tuch.   

Abstract

Successful gene targeting in human embryonic stem (hES) cells requires the use of primary fibroblast feeder layers, which assist in the maintenance of the pluripotent state of hES cells. Such feeder layers must also survive any further selection strategy for hES cells. Here we report the production of a novel transgenic human fetal fibroblast (tHFF) as a feeder layer that is resistant to puromycin and can be used for gene targeting and selection of positive clones in hES cells. tHFFs survive under a wide range of puromycin concentrations (0.5-2 microg/ml) and also supports the undifferentiated growth of hES cells. We have demonstrated here that tHFFs are suitable for selecting Envy-hES cells that were transfected with a green fluorescent protein-small interfering RNA (GFP-siRNA) plasmid construct to induce GFP gene down-regulation. The later studies were designed to isolate and propagate stably knockdown cells. tHFFs thus can be used for targeting other genes that would serve as a model to select and understand the differentiation process in hES cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105409     DOI: 10.1089/scd.2006.15.741

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  4 in total

Review 1.  Substrates and supplements for hESCs: a critical review.

Authors:  Melisa Candela Crocco; Nilo Fratnz; Adriana Bos-Mikich
Journal:  J Assist Reprod Genet       Date:  2013-01-04       Impact factor: 3.412

2.  Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.

Authors:  Camille Nicoleau; Pedro Viegas; Marc Peschanski; Anselme L Perrier
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

3.  Isolation of a native osteoblast matrix with a specific affinity for BMP2.

Authors:  Martin Grünert; Christian Dombrowski; Murali Sadasivam; Kerry Manton; Simon M Cool; Victor Nurcombe
Journal:  J Mol Histol       Date:  2007-08-08       Impact factor: 2.611

4.  Dosage and cell line dependent inhibitory effect of bFGF supplement in human pluripotent stem cell culture on inactivated human mesenchymal stem cells.

Authors:  Tara Quang; Maribel Marquez; Giselle Blanco; Yuanxiang Zhao
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.